KYMRIAH™ (01-17-2018)

Generic Name: tisagenlecleucel Trade Name: KYMRIAH For which conditions is this drug approved? KYMRIAH is indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second... Continue Reading

Kisqali® (06-9-2017)

Class: Biological Therapy Generic Name: ribociclib Trade Name: Kisqali® For which conditions is this drug approved? Kisqali is used in combination with another medicine as the first hormonal-based therapy to treat post-menopausal women with hormone... Continue Reading

Kineret® (06-9-2017)

Class: Biologic Therapy Generic Name: anakinra Trade Name: Kineret® How is this drug used? Kineret is approved for adults to reduce the signs and symptoms and slow the damage of moderate to severe rheumatoid arthritis (RA) when one or more other drugs... Continue Reading

Krystexxa (12-16-2015)

  Class: Antihyperuricemic (antigout) agent Generic Name: Pegloticase Trade Name: Krystexxa® For which conditions is this drug approved? Krystexxa is approved for use in adults to help reduce the signs and symptoms of gout that are not controlled... Continue Reading

KRAS gene (08-21-2015)

A gene that may cause cancer when it is mutated (changed). The KRAS gene makes the KRAS protein, which is involved in cell signaling pathways, cell growth, and apoptosis (cell death). Agents that block the activity of the mutated KRAS gene or its protein... Continue Reading

Kinase (08-21-2015)

A type of enzyme (a protein that speeds up chemical reactions in the body) that adds chemicals called phosphates to other molecules, such as sugars or proteins. This may cause other molecules in the cell to become either active or inactive. Kinases are... Continue Reading

Keytruda® (11-14-2014)

Class: Biological Therapy Generic Name: pembrolizumab Trade Name: Keytruda® For which conditions is this drug approved? Keytruda is approved for: a) initial treatment of metastatic melanoma, melanoma that is unresectable and metastatic melanoma with... Continue Reading

Kadcyla® (11-8-2014)

Class: Biological Therapy Generic Name: ado-trastuzumab emtansine Trade Name: Kadcyla® For which conditions is this drug approved? Kadcyla is indicated as a single agent for the treatment of patients with HER2-positive, metastatic breast cancer who... Continue Reading

Kyprolis® (08-23-2012)

Class: Biological Therapy Generic Name: carfilzomib Trade Name: Kyprolis® How is this drug used? Kyprolis is used to treat multiple myeloma that is worsening and that has previously been treated with Velcade® (bortezomib) and an immunomodulatory drug... Continue Reading

Kidrolase® (04-28-2009)

Class: Chemotherapy Generic Name: asparaginase (a-SPARE-a-ji-naze), l-asparaginase, erwinia l-asparaginase Trade Name: Elspar®, Kidrolase® For which conditions is this drug approved? Asparaginase is FDA approved for the treatment of acute lymphocytic... Continue Reading

Next Page »